Company Profile

Euclid Diagnostics Inc (AKA: Euclid Diagnostics LLC)
Profile last edited on: 10/30/2014      CAGE: 5C161      UEI: J3Q6U6A4AFF4

Business Identifier: Screening test for prostate cancer
Year Founded
2003
First Award
2010
Latest Award
2013
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1281 Win Hentschel Boulevard
West Lafayette, IN 47906
   (219) 644-3020
   info@eucliddiagnostics.com
   N/A
Location: Single
Congr. District: 04
County: Tippecanoe

Public Profile

Euclid Diagnostics, LLC is biotechnology company developing new test to detect prostate cancer. The company's screening test will help identify individuals who require biopsies. Many prostate biopsies performed each year are needless and could be avoided with the test being developed by Euclid. The company's technology uses a set of twelve biomarkers to determine the presence of cancer. The test would replace the currently employed and inferior PSA test.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
10-14

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2013 1 NIH $287,585
Project Title: A Diagnostic Test For The Detection Of Prostate Cancer From Urine Dna
2010 1 NIH $394,453
Project Title: A Diagnostic Test For Improved Prostate Cancer Diagnosis In Abnormal Biopsies

Key People / Management

  Igor Brikun -- Scientist

  Diha J Freije -- Chief Scientific Officer

Company News

There are no news available.